Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Equity (2016 - 2026)

Catalyst Pharmaceuticals filings provide 16 years of Return on Equity readings, the most recent being 0.0% for Q1 2026.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Equity hit 0.0% in Q1 2026 for Catalyst Pharmaceuticals, down from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q2 2023 to a low of 0.0% in Q2 2024.
  • Median Return on Equity over the past 5 years was 0.0% (2024), compared with a mean of 0.0%.
  • The widest YoY moves for Return on Equity: up 0bps in 2022, down 0bps in 2022.
  • Catalyst Pharmaceuticals' Return on Equity stood at 0.0% in 2022, then crashed by -55bps to 0.0% in 2023, then surged by 53bps to 0.0% in 2024, then dropped by 0bps to 0.0% in 2025, then dropped by -1bps to 0.0% in 2026.
  • The last three reported values for Return on Equity were 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025) per Business Quant data.